4Yeh TC,Zhang W,Ildstad ST,et al.In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles.Magn Reson Med,1995,33:200-208.
5Weissleder R,Stark DD,Engelstad BL,et al.Superparamagnetic iron oxide:pharmacokinetics and toxicity.AJR,1989,152:167-173.
6Jendelova P,Herynek V,Urdzikova L,et al.Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord.J Neurosci Res,2004,76:232-243.
7Josephson L,Tung CH,Moore A,et al.High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.Bioconjug Chem,1999,10:186-191.
8Frank JA,Miller BR,Arbab AS,et al.Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.Radiology,2003,228:480-487.
9Bulte JW,Douglas T,Witwer B,et al.Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells.Nat Biotechnol,2001,19:1141-1147.
10Arbab AS,Yocum GT,Kalish H,et al.Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.Blood,2004,104:1217-1223.
二级参考文献21
1Weissleder R. Molecular imaging: exploring the next frontier.Radiology, 1999, 212: 609-614.
2Unger EC. How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology, 2003, 229: 615-616.
3Bicknese AR, Goodwin HS, Quinn CO, et al. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant, 2002, 11:261-264.
4Deans R J, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 2000, 28: 875-884.
5Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol, 2000, 109 : 235-242.
6Yeh TC, Zhang W, Ildstad ST, et al. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles.Magn Reson Med, 1995, 33:200-208.
7Josephson L, Tung CH, Moore A, et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide coniuzates. Bioconiuz Chem, 1999, 10: 186-191.
8Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology,2003, 228: 760-767.
9Weissleder R, Stark DD, Engelstad BL, et al. Superparamagetic iron oxide: pharmacokinetics and toxicity. AJR, 1989,152: 167-173.
10Lee IH, Bulte JW, Schweinhardt P, et al. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol, 2004, 187: 509-516.
